-transparent.png){kind=logo}
The trout red blood cell Na+/H+ antiporter (beta NHE) plays two interesting properties: it is the only NHE own to be activated by cyclic AMP, and the activation process is followed by a desensitisation of the transport system itself. Cloning and expression of beta NHE have provided inificant information about Na+/H+ activation, in particular that activation by cyclic AMP is directly dependent upon the presence of two protein kinase A consensus sites in the cytoplasmic tail of the antiporter. Expression of beta NHE in fibroblasts demonstrates that the protein kinase A (PKA) and protein kinase C (PKC) activation pathways are independent and do not converge a common kinase. Moreover, the hydrophilic C-terminal fragment is essential to the mediation of the various hormonal responses. NHE1 (the human ubiquitous isoform) is not activated by cyclic AMP, but a "NHE1 transmembrane domain/beta NHE cytoplasmic domain' chimera is fully activated by cyclic AMP. In red cells, activation of beta NHE is the result of phosphorylation by PKA of at least two independent sites. Desensitisation, inhibited by the phosphatase inhibitor okadaic acid, may consist of the dephosphorylation of one of these two sites. Furthermore, Calyculin A (CIA), another specific protein phosphatase inhibitor, induces in unstimulated cells a Na+/H+ exchange activity whose exchange properties are very different from those of the adrenergically stimulated antiporter. It is suggested that CIA may be able to revive "sequestered' antiporters. We propose that the molecular events underlying beta NHE desensitisation could be similar to those involved in rhodopsin desensitisation. Antibodies were generated against trout red cell arrestin in order to analyse the binding of arrestin to the activated exchanger. Recombinant trout arrestin was produced in a protease-deficient strain of Escherichia coli and its functionality tested in a reconstituted rhodopsin assay.
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
April 1988,
The Journal of general physiology,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
September 1990,
The Journal of physiology,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
August 1993,
The Journal of laboratory and clinical medicine,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
September 1992,
Nihon rinsho. Japanese journal of clinical medicine,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
June 1993,
The American journal of physiology,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
November 1991,
The Journal of clinical investigation,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
August 1989,
The Journal of general physiology,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
May 1994,
Biochemical Society transactions,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
April 1989,
The American journal of physiology,
M Malapert, and
H Guizouarn, and
B Fievet, and
R Jahns, and
F Garcia-Romeu, and
R Motais, and
F Borgese
November 1987,
The American journal of physiology,
